These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16305421)

  • 1. Decrease in Fungizone toxicity induced by the use of Lipofundin as a dilutent: an in vitro study.
    de Araújo IB; Damasceno BP; de Medeiros TM; Soares LA; do Egito ES
    Curr Drug Deliv; 2005 Apr; 2(2):199-205. PubMed ID: 16305421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similarity between the in vitro activity and toxicity of two different Fungizone/Lipofundin admixtures.
    Araújo IB; Brito CR; Urbano IA; Dominici VA; Silva Filho MA; Silveira WL; Damasceno BP; Medeiros AC; Egito ES
    Acta Cir Bras; 2005; 20 Suppl 1():257-61. PubMed ID: 16186987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphotericin B/emulsion admixture interactions: an approach concerning the reduction of amphotericin B toxicity.
    Egito ES; Araújo IB; Damasceno BP; Price JC
    J Pharm Sci; 2002 Nov; 91(11):2354-66. PubMed ID: 12379920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the toxicity of a new lipid complex formulation of amphotericin B.
    Larabi M; Pages N; Pons F; Appel M; Gulik A; Schlatter J; Bouvet S; Barratt G
    J Antimicrob Chemother; 2004 Jan; 53(1):81-8. PubMed ID: 14657087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of aggregation state on the toxicity of different amphotericin B preparations.
    Espada R; Valdespina S; Alfonso C; Rivas G; Ballesteros MP; Torrado JJ
    Int J Pharm; 2008 Sep; 361(1-2):64-9. PubMed ID: 18599228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of free and liposomal amphotericin B with renal proximal tubular cells in primary culture.
    Joly V; Saint-Julien L; Carbon C; Yeni P
    J Pharmacol Exp Ther; 1990 Oct; 255(1):17-22. PubMed ID: 2213553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro and in-vivo evaluation of a new amphotericin B emulsion-based delivery system.
    Tabosa Do Egito ES; Appel M; Fessi H; Barratt G; Puisieux F; Devissaguet JP
    J Antimicrob Chemother; 1996 Sep; 38(3):485-97. PubMed ID: 8889723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of sodium deoxycholate sulfate as a lipid drug carrier to enhance the solubility, stability and safety of an amphotericin B inhalation formulation.
    Gangadhar KN; Adhikari K; Srichana T
    Int J Pharm; 2014 Aug; 471(1-2):430-8. PubMed ID: 24907597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Emulsion of amphotericin B in Intralipid 20%: in vitro and in vivo efficacy].
    Chavanet P; Charlier N; Brenet A; Goux A; Muggéo E; Caillot D; Casasnovas O; Kistermann JP; Waldner A; Portier H
    Pathol Biol (Paris); 1992 May; 40(5):507-12. PubMed ID: 1495835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity of an effective amphotericin B formulation at high cationic lipid to drug molar ratio.
    Lincopan N; Borelli P; Fock R; Mamizuka EM; Carmona-Ribeiro AM
    Exp Toxicol Pathol; 2006 Nov; 58(2-3):175-83. PubMed ID: 16982179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphotericin B-entrapping lipid nanoparticles and their in vitro and in vivo characteristics.
    Jung SH; Lim DH; Jung SH; Lee JE; Jeong KS; Seong H; Shin BC
    Eur J Pharm Sci; 2009 Jun; 37(3-4):313-20. PubMed ID: 19491021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of the selective toxicity of amphotericin B incorporated into liposomes.
    Juliano RL; Grant CW; Barber KR; Kalp MA
    Mol Pharmacol; 1987 Jan; 31(1):1-11. PubMed ID: 3807887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How can micelle systems be rebuilt by a heating process?
    Silva-Filho MA; Siqueira SD; Freire LB; Araújo IB; Holanda e Silva KG; Medeiros Ada C; Araújo-Filho I; Oliveira AG; Egito ES
    Int J Nanomedicine; 2012; 7():141-50. PubMed ID: 22275830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High purity amphotericin B.
    Cleary JD; Chapman SW; Swiatlo E; Kramer R
    J Antimicrob Chemother; 2007 Dec; 60(6):1331-40. PubMed ID: 17921178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low nephrotoxicity of an effective amphotericin B formulation with cationic bilayer fragments.
    Lincopan N; Mamizuka EM; Carmona-Ribeiro AM
    J Antimicrob Chemother; 2005 May; 55(5):727-34. PubMed ID: 15761070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative pharmacokinetics and safety of a novel lyophilized amphotericin B lecithin-based oil-water microemulsion and amphotericin B deoxycholate in animal models.
    Brime B; Frutos P; Bringas P; Nieto A; Ballesteros MP; Frutos G
    J Antimicrob Chemother; 2003 Jul; 52(1):103-9. PubMed ID: 12805269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amphotericin B encapsulated in micelles based on poly(ethylene oxide)-block-poly(L-amino acid) derivatives exerts reduced in vitro hemolysis but maintains potent in vivo antifungal activity.
    Adams ML; Andes DR; Kwon GS
    Biomacromolecules; 2003; 4(3):750-7. PubMed ID: 12741794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphotericin B incorporated into egg lecithin-bile salt mixed micelles: molecular and cellular aspects relevant to therapeutic efficacy in experimental mycoses.
    Brajtburg J; Elberg S; Kobayashi GS; Bolard J
    Antimicrob Agents Chemother; 1994 Feb; 38(2):300-6. PubMed ID: 8192456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the leishmanicidal activity of fungizone, liposomal AmB and amphotericin B incorporated into egg lecithin-bile salt mixed micelles.
    Ramos H; Brajtburg J; Marquez V; Cohen BE
    Drugs Exp Clin Res; 1995; 21(6):211-6. PubMed ID: 8907695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the freeze-drying process on the physicochemical and biological properties of pre-heated amphotericin B micellar systems.
    Siqueira SD; Silva-Filho MA; Silva CA; Araújo IB; Silva AE; Fernandes-Pedrosa MF; Oliveira AG; Egito ES
    AAPS PharmSciTech; 2014 Jun; 15(3):612-9. PubMed ID: 24510525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.